Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Post-Market Pharmacoepidemiologic Study Guidance Is 3 Years Away

Executive Summary

FDA told participants at a May 7 workshop that it plans to have draft guidance for conducting post-market pharmacoepidemiologic safety studies ready for review in fiscal 2010, with final guidance to be released a year later

You may also be interested in...

Electronic Healthcare Data Can Be Used With Caution In Observational Safety Studies, FDA Says

Guidance advises investigators how to work around limitations of electronic healthcare data; agency does not advocate specific type of study design but notes advantages of new (incident) user design.

FDA/WebMD Partnership Is Data-Gathering Opportunity

Deal with WebMD enables FDA to reach more consumers though online polling techniques; the agency will also provide videos to the consumer Web site.

E-Prescribing Incentives Offer Model For Electronic Records – CBO’s Orszag

Proponents of the universal adoption of electronic health records might look to follow the "carrot and stick" incentives for electronic prescribing created by the new Medicare Improvements Act, Congressional Budget Office Director Peter Orszag suggests

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts